Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
about
Cancer prevention with promising natural products: mechanisms of action and molecular targetsDown-regulated CFTR During Aging Contributes to Benign Prostatic HyperplasiaEffects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancerVitamin D metabolism and action in the prostate: implications for health and disease.Many putative endocrine disruptors inhibit prostaglandin synthesis.A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.Constituents from Vigna vexillata and their anti-inflammatory activity.Soy food supplementation, dietary fat reduction and peripheral blood gene expression in postmenopausal women--a randomized, controlled trialSoy isoflavones and prostate cancer: a review of molecular mechanisms.Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.Germinated brown rice and its role in human health.Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomyPhase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyChemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidenceCombination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.Adverse influence of coumestrol on secretory function of bovine luteal cells in the first trimester of pregnancy.Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
P2860
Q27006530-C3DA5357-38A1-447C-8E2D-429712CB998FQ28575323-CFA54424-7BF2-405F-9DEB-6E0540786243Q33787995-DC203D77-6BF1-41BB-BDAD-BFD48AA19D6EQ34027269-05A5E263-8CD8-4556-B43A-2EC3C98E66B2Q34834713-416B27F4-898A-4176-9C83-73B001B39F37Q35884192-B2C1B68F-C708-43E3-84EA-CCCFD052BF13Q36202289-14BFB036-C35B-4C76-9506-2B7508B356B3Q37284545-B39150F6-C854-448D-BA4A-0BF2F0501B3BQ37654590-CDB0E87A-80F4-49A9-95E7-A6F5134A0ACFQ37705424-F5EBD8CA-37B3-49DC-82B2-97E8EB60F194Q38079843-D14438E0-5CF3-4A6A-9A18-54DCC1532A89Q39068984-34399C53-5866-416A-A208-FCDB32F1EC66Q39264461-7D91F239-6AA6-4FD4-A1FA-AB6E4717CC1EQ39924579-4A67EA41-F038-4E21-8D1B-982D1E682D69Q41776928-30181738-66A6-4B41-BE1B-FBCA39A939F4Q42732583-75876EDC-199A-4157-931E-4AF05FEEA794Q57109257-7B917962-E25B-4CF8-878F-325D3703E013
P2860
Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Inhibition of prostaglandin sy ...... s in prostate cancer patients.
@en
type
label
Inhibition of prostaglandin sy ...... s in prostate cancer patients.
@en
prefLabel
Inhibition of prostaglandin sy ...... s in prostate cancer patients.
@en
P2093
P2860
P356
P1476
Inhibition of prostaglandin sy ...... s in prostate cancer patients.
@en
P2093
Aruna V Krishnan
Christopher Gardner
David Feldman
Donna M Peehl
Jacqueline Moreno
James D Brooks
Rumi S Bhattacharyya
Srilatha Swami
P2860
P304
P356
10.1002/IJC.24161
P577
2009-05-01T00:00:00Z